Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6077
Rank
HK$5.37 B
Marketcap
HK$268.76
Share price
-2.41%
Change (1 day)
-16.08%
Change (1 year)

Financial Statements

Thumbnail Avalon Pharma (Middle East Pharmaceutical) Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement